Literature DB >> 15639800

Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy.

D L Pountney1, T M Treweek, T Chataway, Y Huang, F Chegini, P C Blumbergs, M J Raftery, W P Gai.   

Abstract

Multiple system atrophy (MSA) is characterized by the formation of oligodendroglial cytoplasmic inclusions (GCIs) consisting of alpha-synuclein filaments. AlphaB-crystallin, a small chaperone protein that binds to unfolded proteins and inhibits aggregation, has been documented in GCIs. We investigated the relative abundance and speciation of alphaB-crystallin in GCIs in MSA brains. We also examined the influence of alphaB-crystallin on the formation of cytoplasmic inclusions in cultured glial cells. Immunohistochemistry and confocal microscopy revealed alphaB-crystallin is a prominent component of GCIs, more abundant than in Lewy bodies in Lewy body dementia. One- and two-dimensional gel electrophoresis and mass spectrometric analysis of GCIs immunopurified from MSA brains indicated that alphaB-crystallin is a major protein component with multiple post-translationally modified species. In cultured C6 glioma cells treated with the proteasomal inhibitor, lactacystin, to induce accumulation of ubiquitinated proteins, a subset of cells showed increased cytoplasmic staining for alphaB-crystallin. Proteasome-inhibited cells transfected with GFP-tagged alpha-synuclein resulted in ubiquitin- and alphaB-crystallin-positive aggregates resembling GCIs in MSA brains. Our results indicate that alphaB-crystallin is a major chaperone in MSA, and suggest a role of the protein in the formation of inclusion bodies in glial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639800     DOI: 10.1007/BF03033778

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  39 in total

1.  Tracking pathology with proteomics: identification of in vivo degradation products of alphaB-crystallin.

Authors:  C M Colvis; Y Duglas-Tabor; K B Werth; N E Vieira; J A Kowalak; A Janjani; A L Yergey; D L Garland
Journal:  Electrophoresis       Date:  2000-06       Impact factor: 3.535

Review 2.  Hassles with taking out the garbage: aggravating aggresomes.

Authors:  Rafael Garcia-Mata; Ya-Sheng Gao; Elizabeth Sztul
Journal:  Traffic       Date:  2002-06       Impact factor: 6.215

3.  alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.

Authors:  C Richter-Landsberg; M Gorath; J Q Trojanowski; V M Lee
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

Review 4.  Alpha-B-crystallin in neuropathology.

Authors:  A F van Rijk; H Bloemendal
Journal:  Ophthalmologica       Date:  2000 Jan-Feb       Impact factor: 3.250

Review 5.  The intracellular localization of the proteasome.

Authors:  C Gordon
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

6.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

7.  Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.

Authors:  Kevin St P McNaught; Daniel P Perl; Anna-Liisa Brownell; C Warren Olanow
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

8.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Authors:  Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

Review 9.  The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself.

Authors:  I Dalle-Donne; R Rossi; A Milzani; P Di Simplicio; R Colombo
Journal:  Free Radic Biol Med       Date:  2001-12-15       Impact factor: 7.376

10.  Altered proteasomal function in sporadic Parkinson's disease.

Authors:  Kevin St P McNaught; Roger Belizaire; Ole Isacson; Peter Jenner; C Warren Olanow
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  17 in total

Review 1.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

Review 2.  Biochemical, cellular and behavioural aspects of neurodegeneration: the view from down under.

Authors:  David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 3.  Heat shock protein 27: its potential role in vascular disease.

Authors:  Gordon Ferns; Sedigheh Shams; Shahida Shafi
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

Review 4.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 5.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 6.  The multifaceted nature of αB-crystallin.

Authors:  Junna Hayashi; John A Carver
Journal:  Cell Stress Chaperones       Date:  2020-05-07       Impact factor: 3.667

7.  Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity.

Authors:  Heath Ecroyd; Sarah Meehan; Joseph Horwitz; J Andrew Aquilina; Justin L P Benesch; Carol V Robinson; Cait E Macphee; John A Carver
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

8.  Synphilin-1 inhibits alpha-synuclein degradation by the proteasome.

Authors:  Beatriz Alvarez-Castelao; José G Castaño
Journal:  Cell Mol Life Sci       Date:  2010-11-20       Impact factor: 9.261

9.  Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation.

Authors:  Tiago Fleming Outeiro; Jochen Klucken; Katherine E Strathearn; Fang Liu; Paul Nguyen; Jean-Christophe Rochet; Bradley T Hyman; Pamela J McLean
Journal:  Biochem Biophys Res Commun       Date:  2006-10-26       Impact factor: 3.575

10.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.